Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03042611
Title Efficacy and Safety Trial of Apatinib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Patients With Gastric Cancer
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors LSK BioPartners Inc.
Indications

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

Therapies

Rivoceranib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | DEU


No variant requirements are available.